Could platelet indices be new biomarkers for inflammatory bowel diseases?

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 3, 2013, Pages 334-341

  Ozturk Z A ^a   Dag, M S ^a   Kuyumcu, M E ^b   Cam, H ^a   Yesil, Y ^b   Yilmaz, N ^a   Aydinli, M ^a   Kadayifci, A ^a   Kepekci, Y ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Blood platelet count; Crohn's disease; Inflammation; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; REMISSION; THROMBOCYTE; THROMBOCYTE VOLUME; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84878549462     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. FIOCCHI C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
2. MEUWIS MA, FILLET M, GEURTS P, DE SENY D, LUTTERI L, CHAPELLE JP, BOURS V, WEHENKEL L, BELAICHE J, MALAISE M, LOUIS E, MERVILLE MP. Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol 2007; 73: 1422-1433.
3. CELLIER C, SAHMOUD T, FROGUEL E, ADENIS A, BELAICHE J, BRETAGNE JF, FLORENT C, BOUVRY M, MARY JY, MODIGLIANI R. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut 1994; 35: 231-235.
4. SOLEM CA, LOFTUS EV, TREMAINE WJ, HARMSEN WS, ZINSMEISTER AR, SANDBORN WJ. Correlation of Creactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 707-712.
5. MACK DR, LANGTON C, MARKOWITZ J, LELEIKO N, GRIFFITHS A, BOUSVAROS A, EVANS J, KUGATHASAN S, OTLEY A, PFEFFERKORN M, ROSH J, MEZOFF A, MOYER S, OLIVA-HEMKER M, ROTHBAUM R, WYLLIE R, DELROSARIO JF, KELJO D, LERER T, HYAMS J, GROUP PIBDCR. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007; 119: 1113-1119.
6. XIANG JY, OUYANG Q, LI GD, XIAO NP. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.World J Gastroenterol 2008; 14: 53-57.
7. YÜKSEL O, HELVACI K, BA AR O, KÖKLÜ S, CANER S, HELVACI N, ABAYLI E, ALTIPARMAK E. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009; 20: 277-281.
8. CAKAL B, AKOZ AG, USTUNDAG Y, YALINKILIC M, ULKER A, ANKARALI H. Red cell distribution width for assessment of activity of inflammatory bowel disease. Dig Dis Sci 2009; 54: 842-847.
9. SANTIMONE I, DI CASTELNUOVO A, DE CURTIS A, SPINELLI M, CUGINO D, GIANFAGNA F, ZITO F, DONATI MB, CERLETTI C, DE GAETANO G, IACOVIELLO L, INVESTIGATORS MSP. White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica 2011; 96: 1180-1188.
10. LANCÉ MD, VAN OERLE R, HENSKENS YM, MARCUS MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol 2010; 16: 28-31.
11. TRUELOVE SC, WITTS LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 2: 1041-1048.
12. RACHMILEWITZ D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 298: 82-86.
13. POLI SKA B, MATOWICKA-KARNA J, KEMONA H. The cytokines in inflammatory bowel disease. Postepy Hig Med Dosw (Online) 2009; 63: 389-394.
14. VERMEIRE S, VAN ASSCHE G, RUTGEERTS P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006; 55: 426-431.
15. BEYAZIT Y, KOKLU S, TAS A, PURNAK T, SAYILIR A, KURT M, TURHAN T, CELIK T, SUVAK B, TORUN S, AKBAL E. Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. J Crohns Colitis 2012; 6: 102-107.
16. HENRIKSEN M, JAHNSEN J, LYGREN I, STRAY N, SAUAR J, VATN MH, MOUM B, GROUP IS. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a p rospective population-based study. Gut 2008; 57: 1518-1523.
17. DANESE S, MOTTE CD CEL, FIOCCHI C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004; 99: 938-945.
18. CHU SG, BECKER RC, BERGER PB, BHATT DL, EIKELBOOM JW, KONKLE B, MOHLER ER, REILLY MP, BERGER JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8: 148-156.
19. WIWANITKIT V. Platelet crit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost 2004; 10: 175-178.
20. THREATTE GA. Usefulness of the mean platelet volume. Clin Lab Med 1993; 13: 937-950.
21. BATH PM, BUTTERWORTH RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161.
22. KARPATKIN S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 1969; 48: 1083-1087.
23. TURHAN O, COBAN E, INAN D, YALCIN AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit 2010; 16: CR202-205.
24. KISACIK B, TUFAN A, KALYONCU U, KARADAG O, AKDOGAN A, OZTURK MA, KIRAZ S, ERTENLI I, CALGUNERI M. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008; 75: 291-294.
25. SAHIN BALCIK O, BILEN S, ULUSOY EK, AKDENIZ D, UYSAL S, IKIZEK M, AK F, KOSAR A. Thrombopoietin and mean platelet volume in patients with ischemic stroke. Clin Appl Thromb Hemost 2012.
26. ALBAYRAK Y, ALBAYRAK A, ALBAYRAK F, YILDIRIM R, AYLU B, UYANIK A, KABALAR E, GÜZEL IC. Mean platelet volume: a new predictor in confirming acute appendicitis diagnosis. Clin Appl Thromb Hemost 2011; 17: 362-366.
27. DOGAN Y, SOYLU A, EREN GA, POTUROGLU S, DOLAPCIOGLU C, SONMEZ K, DUMAN H, SEVINDIR I. Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients. Int J Med Sci 2011; 8: 540-546.
28. KAPSORITAKIS AN, KOUKOURAKIS MI, SFIRIDAKI A, POTAMIANOS SP, KOSMADAKI MG, KOUTROUBAKIS IE, KOUROUMALIS EA. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96: 776-781.
29. JÄREMO P, SANDBERG-GERTZEN H. Platelet density and size in inflammatory bowel disease. Thromb Haemost 1996; 75: 560-561.
30. ZUBCEVIC N, MESIHOVIC R, ZUBCEVIC S. Usefulness of laboratory data in estimation of Crohn's disease activity. Med Arch 2010; 64: 33-36.
31. DOUDA T, BURES J, REJCHRT S, KOPÁCOVÁ M, PECKA M, MALÝ J. Mean platelet volume (MPV) in Crohn's disease patients. Cas Lek Cesk 2006; 145: 870-873.
32. KAMATH S, BLANN AD, LIP GY. Platelet activation: assessment and quantification. Eur Heart J 2001; 22: 1561-1571.
33. NENA E, PAPANAS N, STEIROPOULOS P, ZIKIDOU P, ZAROGOULIDIS P, PITA E, CONSTANTINIDIS TC, MALTEZOS E, MIKHAILIDIS DP, BOUROS D. Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets. 2012; 23: 447-454. Epub 2011 Nov 10.
34. DALAMAGA M, KARMANIOLAS K, LEKKA A, ANTONAKOS G, THRASYVOULIDES A, PAPADAVID E, SPANOS N, DIONYSSIOU-ASTERIOU A. Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Dis Markers 2010; 29: 55-61.
35. TOZKOPARAN E, DENIZ O, UCAR E, BILGIC H, EKIZ K. Changes in platelet count and indices in pulmonary tuberculosis. Clin Chem Lab Med 2007; 45: 1009-1013.